header.html

An official website of the European Union How do you know?      
European Commission logo

handle.jsp

cover
In solid tumors, the limited penetration of radionuclide carriers prohibits the use of alpha-particles due to their short range which would result in partial tumor irradiation with limited killing efficacy. However, excluding transport considerations, alphas are extremely potent. To explore the potential of alphas against solid tumors, we study non-targeted liposomes that are triggered to release highly-diffusive forms of the alpha-particle generator Actinium-225 (Ac-225) within the tumor interstitium. The rationale is that nanometer-sized liposome carriers would enable enhanced (heterogeneous) uptake of radioactivity by the tumor, and that the triggered release of encapsulated Ac-225 within the interstitium would result in deeper penetration of the alpha-emitter improving uniformity in tumor irradiation.
2015-07-14
SOC NUCLEAR MEDICINE INC
JRC94666
0161-5505,   
http://jnm.snmjournals.org/content/56/supplement_3.toc,    https://publications.jrc.ec.europa.eu/repository/handle/JRC94666,   
NameCountryCityType
Datasets
IDTitlePublic URL
Dataset collections
IDAcronymTitlePublic URL
Scripts / source codes
DescriptionPublic URL
Additional supporting files
File nameDescriptionFile type 

footer.html